ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      4,967.23
      -0.88%
      US Tech 100
      16,568.00
      -2.18%
      Dow Jones
      37,986.40
      0.56%
      Brent Oil
      86.625
      0.24%
      Bitcoin
      64,366.06
      1.35%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Osiris Therape (MM) (OSIR)

      7. Osiris Therape (MM) (OSIR) News

      OSIR

      Osiris Therapeutics, Inc. (OSIR)

      Osiris Therape (MM)
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:OSIR
      DateTimeSourceHeadlineSymbolCompany
      04/29/20194:13PMEdgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(b) (15-12b)NASDAQ:OSIROsiris Therape (MM)
      04/17/20199:48AMEdgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ...NASDAQ:OSIROsiris Therape (MM)
      04/17/20199:37AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OSIROsiris Therape (MM)
      04/17/20199:37AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OSIROsiris Therape (MM)
      04/17/20199:36AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OSIROsiris Therape (MM)
      04/17/20199:19AMEdgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:OSIROsiris Therape (MM)
      04/17/20199:18AMEdgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:OSIROsiris Therape (MM)
      04/17/20199:18AMEdgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:OSIROsiris Therape (MM)
      04/17/20199:18AMEdgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:OSIROsiris Therape (MM)
      04/17/20199:18AMEdgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:OSIROsiris Therape (MM)
      04/17/20199:15AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OSIROsiris Therape (MM)
      04/17/20199:05AMGlobeNewswire Inc.Osiris Therapeutics, Inc. Announces Closing of Acquisition by Smith & Nephew plcNASDAQ:OSIROsiris Therape (MM)
      04/17/20196:08AMEdgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:OSIROsiris Therape (MM)
      04/17/20196:08AMEdgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:OSIROsiris Therape (MM)
      04/16/20199:02AMEdgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:OSIROsiris Therape (MM)
      04/12/20198:57AMEdgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:OSIROsiris Therape (MM)
      04/10/20199:34AMEdgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:OSIROsiris Therape (MM)
      04/10/20199:30AMEdgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:OSIROsiris Therape (MM)
      03/27/20195:20PMEdgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:OSIROsiris Therape (MM)
      03/27/20195:13PMEdgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:OSIROsiris Therape (MM)
      03/20/20197:43AMEdgar (US Regulatory)Statement of Ownership: Solicitation (sc 14d9)NASDAQ:OSIROsiris Therape (MM)
      03/20/20197:33AMEdgar (US Regulatory)Tender Offer Statement by Third Party (sc To-t)NASDAQ:OSIROsiris Therape (MM)
      03/15/20196:13PMPR Newswire (US)SHAREHOLDER ALERT: WeissLaw LLP Investigates Osiris Therapeutics, Inc.NASDAQ:OSIROsiris Therape (MM)
      03/15/20199:03AMEdgar (US Regulatory)Annual Report (10-k)NASDAQ:OSIROsiris Therape (MM)
      03/12/20195:10PMEdgar (US Regulatory)Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)NASDAQ:OSIROsiris Therape (MM)
      03/12/20195:07PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OSIROsiris Therape (MM)
      03/12/20195:03PMEdgar (US Regulatory)Written Communication Relating to an Issuer or Third Party (sc To-c)NASDAQ:OSIROsiris Therape (MM)
      03/12/20191:14PMPR Newswire (US)ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Osiris Therapeutics, Inc.NASDAQ:OSIROsiris Therape (MM)
      03/12/20199:33AMPR Newswire (US)Smith & Nephew expands in high growth regenerative medicine market through acquisition of Osiris Therapeutics, Inc.NASDAQ:OSIROsiris Therape (MM)
      03/12/20199:22AMEdgar (US Regulatory)Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)NASDAQ:OSIROsiris Therape (MM)
       Showing the most relevant articles for your search:NASDAQ:OSIR